1. Pink Sheet
  2. >>Geography

EU’s Innovative Drug Approval Tally Shows Sharp Decline

Just 36 Products With New Active Substances Got The All-Clear In 2023

 
• By Ian Schofield

The numbers may be down, but Europeans will in future be able to gain access to a number of highly innovative medicines, including several products for hard-to-treat cancers, a gene therapy for severe and moderately severe hemophilia B, and two vaccines against disease caused by respiratory syncytial virus.

European flags
The European Commission is responsible for EU drug marketing authorizations • Source: Shutterstock

In 2023, the European Commission approved 36 medicines containing a new active substance, the lowest number since 2019 when just 28 NAS-containing drugs gained an EU-wide marketing authorization.

Among the 36 products were 16 cancer drugs and one gene therapy

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography